5-HT1B antagonists (AstraZeneca)

N/A

Report date: 2026/02/04 10:11:53
NME

Base Information

Drug Name5-HT1B antagonists (AstraZeneca)
Drug Alias Name[N-methyl-3H(3)]AZ-10419369AR-A2 analogs (AstraZeneca)AZ-10419369AZ-12333053M-519351 +[10] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor antagonists
TargetsSerotonin 1b (5-HT1b) receptor
Therapy Area/IndicationsAnxiety DisordersDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersDepression

Other Information

ATC CodeN/A
Related LinksN/A